| Literature DB >> 33853535 |
Carlijn R Lamers1,2, Nicole M de Roos3, Lola J M Koppelman3, Maria T E Hopman4, Ben J M Witteman5,3.
Abstract
BACKGROUND: Physical activity may affect disease activity in patients with inflammatory bowel disease. We used a survey to investigate this association and performed interviews to get a better understanding of patient experiences, and therefore the nature of this association.Entities:
Keywords: Crohn’s disease; Interviews; Physical activity; Ulcerative colitis
Year: 2021 PMID: 33853535 PMCID: PMC8046271 DOI: 10.1186/s12876-021-01739-z
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 3.067
Fig. 1Flowchart of individuals included in analysis
Characteristics of the survey study population consisting of 176 CD and 162 UC participants
| CD | UC | Disease activity CD | Disease activity UC | |||||
|---|---|---|---|---|---|---|---|---|
| Remission | Mild | Moderate | Remission | Mild | Moderate | |||
| Subjects, n (%) | 176 (52.1) | 162 (47.9) | 127 (72.2) | 31 (17.6) | 18 (10.2) | 110 (67.9) | 36 (22.2) | 16 (9.9) |
| Gender, n (%) | ||||||||
| Female | 124 (70.5) | 101 (62.3) | 89 (70.1) | 19 (61.3) | 16 (88.9) | 65 (59.1) | 26 (72.2) | 10 (62.5) |
| Age (years) | 47.6 ± 15.6 | 50.0 ± 14.5 | 47.8 ± 15.7 | 47.2 ± 16.6 | 46.7 ± 13.9 | 49.8 ± 14.0 | 52.5 ± 15.4 | 45.4 ± 15.5 |
| Age at diagnosis (years) | 32.3 ± 14.6* | 35.4 ± 14.1* | 32.6 ± 15.1 | 30.9 ± 14.8 | 32.6 ± 9.4 | 34.3 ± 13.3 | 39.7 ± 15.5 | 33.4 ± 15.5 |
| BMI (kg/m2) | 24.9 ± 4.7 | 24.9 ± 3.8 | 25.0 ± 4.4 | 24.6 ± 4.8 | 25.0 ± 6.6 | 24.6 ± 3.5 | 25.4 ± 3.9 | 25.6 ± 5.6 |
| Smoking, n (%) | ||||||||
| Never | 127 (72.2) | 125 (77.2) | 99 (78.0)a | 19 (61.3)a,b | 9 (50.0)b | 83 (75.5) | 28 (77.8) | 14 (87.5) |
| Current | 18 (10.2) | 6 (3.7) | 10 (7.9) | 6 (19.4) | 2 (11.1) | 4 (3.6) | 1 (2.8) | 1 (6.3) |
| Former | 31 (17.6) | 31 (19.1) | 18 (14.2)a | 6 (19.4)a,b | 7 (38.9)b | 23 (20.9) | 7 (19.4) | 1 (6.3) |
| Education level#, n (%) | ||||||||
| Low | 40 (22.7) | 32 (19.8) | 27 (21.3) | 8 (25.8) | 5 (27.8) | 21 (19.1) | 8 (22.2) | 3 (18.8) |
| Middle | 53 (30.1) | 50 (30.9) | 38 (29.9) | 6 (19.4) | 9 (50.0) | 35 (31.8) | 8 (22.2) | 7 (43.8) |
| High | 83 (47.2) | 80 (49.4) | 62 (48.8) | 17 (54.8) | 4 (22.2) | 54 (49.1) | 20 (55.6) | 6 (37.5) |
| Medication use, n (%) | ||||||||
| Mesalazines | 29 (16.5)** | 102 (63.0)** | 22 (17.3) | 4 (12.9) | 3 (16.7) | 69 (62.7) | 20 (55.6) | 13 (81.3) |
| Corticosteroids | 24 (13.6) | 23 (14.2) | 14 (11.0) | 7 (22.6) | 3 (16.7) | 10 (9.1)a | 9 (25.0)b | 4 (25.0)a,b |
| Immunosuppressants | 76 (43.2)** | 33 (20.4)** | 55 (43.3) | 14 (45.2) | 7 (38.9) | 20 (18.2) | 8 (22.2) | 5 (31.3) |
| Biologicals | 57 (32.4)** | 28 (17.3)** | 35 (27.6)a | 12 (38.7)a,b | 10 (55.6)b | 11 (10.0)a | 9 (25.0)a,b | 8 (50.0)b |
| Other | 24 (13.6) | 12 (7.4) | 14 (11.0) | 6 (19.4) | 4 (22.2) | 5 (4.5)a | 3 (8.3)a,b | 4 (25.0)b |
| No medication use | 36 (20.5) | 29 (17.9) | 30 (23.6) | 5 (16.1) | 1 (5.6) | 23 (20.9) | 6 (16.7) | 0 (0.0) |
| Flare-ups in past year, n (%) | ||||||||
| None | 91 (51.7)* | 63 (38.9)* | 79 (62.2)a | 7 (22.6)b | 5 (27.8)b | 51 (46.4)a | 10 (27.8)a,b | 2 (12.5)b |
| 1–2 flare-ups | 59 (33.5) | 68 (42.0) | 38 (29.9) | 15 (48.4) | 6 (33.3) | 42 (38.2) | 21 (58.3) | 5 (31.3) |
| 3–4 flare-ups | 9 (5.1)* | 18 (11.1)* | 2 (1.6)a | 5 (16.1)b | 2 (11.1)a,b | 9 (8.2)a | 3 (8.3)a | 6 (37.5)b |
| More than 4 flare-ups | 17 (9.7) | 13 (8.0) | 8 (6.3)a | 4 (12.9)a,b | 5 (27.8)b | 8 (7.3) | 2 (5.6) | 3 (18.8) |
| Surgery, n (%) | 60 (34.1)** | 13 (8.0)** | 41 (32.3) | 10 (32.3) | 9 (50.0) | 6 (5.5) | 6 (16.7) | 1 (6.3) |
Data are presented as mean ± SD for normally distributed data. Categorical data is presented as n (%). *p < 0.05; **p < 0.01
CD Crohn’s disease, UC ulcerative colitis, BMI body mass index
#Education level: no education, primary or lower vocational education and lower general secondary education (low); secondary vocational education and higher general secondary education (middle); higher vocational education and university (high)
abGroups with the same superscript letters do not differ significantly after post-hoc analyses using the Bonferroni test (p > 0.05)
Disease activity and physical activity scores of CD and UC participants and stratified for disease activity
| CD | UC | Disease activity CD | Disease activity UC | |||||
|---|---|---|---|---|---|---|---|---|
| Remission | Mild | Moderate | Remission | Mild | Moderate | |||
| Disease activity | ||||||||
| sCDAI score | 95 [48–158] | – | 79 [44–107]a | 175 [165–198]b | 269 [233–326]c | – | – | – |
| Range | 44–357 | – | 44–146 | 150–219 | 220–357 | – | – | – |
| P-SCCAI score | – | 1 [1–3] | – | – | – | 1 [1, 2]a | 3 [3, 4]b | 7 [6–9]c |
| Range | – | 0–13 | – | – | – | 0–2 | 3–5 | 6–13 |
| Physical activity | ||||||||
| Total physical activity score | 6382 ± 3747* | 7329 ± 3989* | 6782 ± 3963a | 5834 ± 2863a,b | 4501 ± 2858b | 7457 ± 4052 | 7501 ± 4160 | 6070 ± 3039 |
| Total minutes per week | 1907 ± 1031* | 2143 ± 1016* | 1979 ± 1071 | 1903 ± 871 | 1413 ± 895 | 2230 ± 1035 | 1989 ± 998 | 1890 ± 890 |
Data are presented as mean ± SD for normally distributed data or median [interquartile range] when skewed. *p < 0.05
CD Crohn’s disease, UC ulcerative colitis, sCDAI short Crohn’s Disease Activity Index, P-SCCAI Patient Simple Clinical Colitis Activity Index
abGroups with the same superscript letters do not differ significantly after post-hoc analyses using the Bonferroni test (p > 0.05)
Results of multiple linear regression of the association between physical activity with disease activity as continuous variables, for CD and UC
| CD (n = 176) | UC (n = 162) | |||
|---|---|---|---|---|
| β-coefficient (95% CI)a | β-coefficient (95% CI)a | |||
| Total physical activity score | ||||
| Crude | − 0.406 (− 0.698 to 0.114) | − 0.006 (− 0.015 to 0.003) | 0.162 | |
| 1 | − 0.395 (− 0.693 to 0.097) | − 0.005 (− 0.014 to 0.004) | 0.293 | |
| 2 | − 0.375 (− 0.668 to 0.081) | − 0.003 (− 0.013 to 0.006) | 0.490 | |
CD disease activity scores can range from 0 to > 450 and UC disease activity scores can range from 0 to 19
Bold values are significant
CD Crohn’s disease, UC ulcerative colitis, CI confidence interval
aPer 100 point increase in total physical activity score
Model 1: adjusted for age (years), gender (m/f), BMI (kg/m2) and education level (low/middle/high)
Model 2: as model 1 plus age at diagnosis (years), medication use (yes/no) and previous IBD-related surgery (yes/no)
Fig. 2Total physical activity score (top) and total minutes per week (bottom) of CD and UC participants stratified for disease activity, divided into light, moderate and vigorous physical activity. Total physical activity score was calculated by summing up the different activity scores which were calculated by the number of minutes per week of that activity times the corresponding metabolic equivalent of task (MET). *p < 0.05. CD Crohn’s disease, UC ulcerative colitis